lifestyle.careersavvy.co.uk

Author: RazorPitch

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Advances ATNM-400 Targeting STEAP-1 Across Prostate, Breast, and Lung Cancer

December 9, 2025
ATNM-400 Targets B7-H3 and Is Being Studied in a Phase 1 Clinical Trial in South Africa

December 8, 2025
Actinium Pharmaceuticals Advances ATNM-400 B7-H3 Candidate Into Phase 1 Clinical Trial in South Africa

December 8, 2025
Aether Holdings, Inc. (NASDAQ: ATHR) Targets $28B AI Analytics Market With a Data-Media Ecosystem Strategy

December 5, 2025
Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch

December 5, 2025
Drone Surveying Set to Grow from $1.97B to $11.49B by 2035 as ZenaTech, Inc. (NASDAQ: ZENA) Expands Its U.S. Footprint

December 4, 2025
The Future of Autonomous Tech: 4 Early-Stage Companies Scaling Rapidly (ZENA, RCAT, BBAI, DPRO)

November 13, 2025